Long-term risks of cannabis include an elevated risk of addiction, altered brain development, impaired educational performance, chronic respiratory tract and psychotic disorders, motor vehicle accidents, and suicide.
In the cohort without baseline MDD, baseline nonmedical opioid use was significantly associated with an increased risk of incident depressive symptoms, but not MDD, over 3 years.
Alkermes has decided to expand the number of retail pharmacies and clinics where patients can receive access to Aristada (aripiprazole lauroxil) and Vivitrol (naltrexone extended-release injectable suspension).
People who receive additional treatment following medically managed opioid withdrawal have reduced mortality compared with those who do not receive treatment.
